Discontinued — last reported Q2 '13
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2008
Last reportedQ2 2013
How to read this metric
Higher levels often indicate significant recent capital investment or large historical acquisitions, while lower levels may suggest aging assets.
Detailed definition
Depreciation and amortization represent the systematic allocation of the cost of tangible and intangible assets over the...
Peer comparison
High in capital-intensive industries like healthcare and manufacturing; peers often report this as a significant non-cash drag on earnings.
Metric ID:
is_depreciation_and_amortizationBusiness Segments
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Oncology & Multispecialty | — | — | — | — | — | — | $71.00M | $63.00M |
| North American Pharmaceutical | — | — | — | — | — | — | $32.00M | $34.00M |
| Medical-Surgical Solutions | $16.00M | $23.00M | $22.00M | $23.00M | $22.00M | $22.00M | $23.00M | $26.00M |
| Prescription Technology Solutions | $19.00M | $21.00M | $22.00M | $22.00M | — | $21.00M | $20.00M | $21.00M |
| International | — | $30.00M | — | — | — | $14.00M | — | — |
| U.S. Pharmaceutical | — | $60.00M | — | — | — | $63.00M | — | — |
| Total | — | — | — | — | — | — | — | — |
International, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
D&A at Other Companies
Frequently Asked Questions
- What does d&a mean?
- The non-cash expense that spreads the cost of physical and intangible assets over their useful life.